|
Sign In to gain access to subscriptions and/or personal tools.
|
Impact of 30-Day Oral Dosing with N-acetyl-L-cysteine on Sprague-Dawley Rat Physiology
Darryl P. Arfsten1
Eric W. Johnson1
Angie R. Thitoff1
Anne E. Jung1
Erin R. Wilfong1
Scott M. Lohrke1
Tim A. Bausman2
Jeffrey S. Eggers3
Andrew J. Bobb1
1 Naval Health Research Center Environmental Health Effects Laboratory, Wright-Patterson Air Force Base, Ohio, USA
2 ManTech Inc., Wright-Patterson Air Force Base, Ohio, USA
3 Air Force Research Laboratory, Brooks Air Force Base, Texas, USA
Correspondence: Address correspondence to Darryl P. Arfsten, PhD, Naval Health Research Center, Environmental Health Effects Laboratory, 2729 R Street, Building 837, Area B, Wright-Patterson AFB OH 45433-7903, USA. E-mail:darryl.arfsten{at}wpafb.af.mil
A number of studies have demonstrated a protective effect associated with N-acetyl-L-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p .05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.
Key Words: Glutathione Glutathione-S-transferase N-acetyl-L-cysteine Oral Toxicity Rats
International Journal of Toxicology, Vol. 23, No. 4,
239-247 (2004)
DOI: 10.1080/10915810490502041

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. L. Baker, M. W. Anglade, E. L. Baker, C. M. White, J. Kluger, and C. I. Coleman
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis
Eur. J. Cardiothorac. Surg.,
March 1, 2009;
35(3):
521 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study
Eur. Heart J.,
March 1, 2008;
29(5):
625 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Carter, S. Hutchison, F. L. Henriquez, D. Legare, M. Ouellette, C. W. Roberts, and A. B. Mullen
Resistance of Leishmania donovani to Sodium Stibogluconate Is Related to the Expression of Host and Parasite {gamma}-Glutamylcysteine Synthetase
Antimicrob. Agents Chemother.,
January 1, 2006;
50(1):
88 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|